Hejaz Hezbollah’s organization funded by suspicious Qatari institution, CID tells court

Hejaz Hezbollah’s organization funded by suspicious Qatari institution, CID tells court

September 23, 2020   11:06 pm

Investigations have revealed that the ‘Save the Pearls’ organization, belonging to currently detained Hejaz Hizbullah, has received funds from an institute in Qatar suspected to be funding terrorist activities.

The Criminal Investigation Department (CID) informed the court today (23), that the said institute had deposited an amount of Rs 13 million to the bank account of the ‘Save the Pearls’ organization.

The relevant institute in Qatar has been identified as a banned organization that provides funding to various terror groups.

Therefore, the CID informed the court that further investigations are being carried out with regard to the Qatari institution.

Disclaimer: All the comments will be moderated by the AD editorial. Abstain from posting comments that are obscene, defamatory or slanderous. Please avoid outside hyperlinks inside the comment and avoid typing all capitalized comments. Help us delete comments that do not follow these guidelines by flagging them(mouse over a comment and click the flag icon on the right side). Do use these forums to voice your opinions and create healthy discourse.

Most Viewed Video Stories

President commends Sri Lanka Army for its unwavering service to the nation (English)

President commends Sri Lanka Army for its unwavering service to the nation (English)

Several parties comment on controversies over the 'Ondansetron' vaccine (English)

Reservoirs continue to overflow, landslides reported amid Northeast Monsoon rains (English)

Justice Minister invites public to share views on proposed new Anti-Terrorism Bill (English)

LIVE🔴Ada Derana Prime Time News Bulletin 6.55 pm

Probe launched after reports of VMS data falling into drug traffickers' hands (English)

PM calls for united front to eradicate ragging, violence and narcotics from universities (English)

Indian pharma company requests independent testing of controversial drug withdrawn in Sri Lanka (English)